Selective estrogen receptor modulator compositions and methods for treatment of disease

Details for Australian Patent Application No. 2008323750 (hide)

Owner The Regents of the University of California Oregon Health & Science University

Inventors Scanlan, Thomas S.; Iijima, Toru

Agent Spruson & Ferguson

Pub. Number AU-A-2008323750

PCT Pub. Number WO2009/062082

Priority 11/938,129 09.11.07 US

Filing date 7 November 2008

Wipo publication date 14 May 2009

International Classifications

C07C 235/38 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/062082 Priority application(s): WO2009/062082

24 November 2011 Alteration of Name

  The name of the applicant has been altered to Oregon Health & Science University of Technology Transfer & Business Development; The Regents of the University of California

15 December 2011 Alteration of Name

  The name of the applicant has been altered to Oregon Health & Science University; The Regents of the University of California

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323756-Solvent recycler

2008323744-Method and apparatus for defining a search window based on distance between access points